Article
In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone.
Microbial drug resistance (Larchmont, N.Y.) - 1 Oct 2016
Roychoudhury Siddhartha, Makin Kelly, Twinem Tracy, Leunk Robert, Hsu Ming Chu
Abstract excerpt
Selection of resistant strains in Streptococcus pneumoniae was studied in vitro with nemonoxacin, a novel nonfluorinated quinolone (NFQ), in comparison with quinolone benchmarks, ciprofloxacin, garenoxacin, and gatifloxacin. In stepwise resistance selection studies, a 256-fold loss of potency was...
Topics
- Anti-Bacterial Agents
- Ciprofloxacin
- Culture Media
- DNA Gyrase
- DNA Topoisomerase IV
- Drug Resistance, Bacterial
- Fluoroquinolones
- Gatifloxacin
- Gene Expression
- Microbial Sensitivity Tests
- Mutation
